Okusaka T - Search Results

1

Plain language summary of the TOPAZ-1 study: durvalumab and chemotherapy for advanced biliary tract cancer.

Oh DY, He AR, Qin S, Chen LT, Okusaka T, Vogel A, Kim JW, Suksombooncharoen T, Lee MA, Kitano M, Burris H, Bouattour M, Tanasanvimon S, McNamara MG, Zaucha R, Avallone A, Tan B, Cundom J, Lee CK, Takahashi H, Ikeda M, Chen JS, Wang J, Makowsky M, Rokutanda N, Żotkiewicz M, Kurland JF, Cohen G, Valle JW. Oh DY, et al. Among authors: okusaka t. Future Oncol. 2023 Nov;19(34):2277-2289. doi: 10.2217/fon-2023-0468. Epub 2023 Sep 25. Future Oncol. 2023. PMID: 37746835 Review.

2

A phase II study of cisplatin in patients with biliary tract carcinoma.

Okada S, Ishii H, Nose H, Yoshimori M, Okusaka T, Aoki K, Iwasaki M, Furuse J, Yoshino M. Okada S, et al. Among authors: okusaka t. Oncology. 1994 Nov-Dec;51(6):515-7. doi: 10.1159/000227396. Oncology. 1994. PMID: 7970496 Clinical Trial.

3

Predictive factors for tumor response to systemic chemotherapy in patients with hepatocellular carcinoma.

Nagahama H, Okada S, Okusaka T, Ishii H, Ikeda M, Nakasuka H, Yoshimori M. Nagahama H, et al. Among authors: okusaka t. Jpn J Clin Oncol. 1997 Oct;27(5):321-4. doi: 10.1093/jjco/27.5.321. Jpn J Clin Oncol. 1997. PMID: 9390209

4

The usefulness of serial changes in serum CA19-9 levels in the diagnosis of pancreatic cancer.

Tanaka N, Okada S, Ueno H, Okusaka T, Ikeda M. Tanaka N, et al. Among authors: okusaka t. Pancreas. 2000 May;20(4):378-81. doi: 10.1097/00006676-200005000-00007. Pancreas. 2000. PMID: 10824692

5

A phase II study of sequential methotrexate and 5-fluorouracil in metastatic pancreatic cancer.

Ikeda M, Okada S, Ueno H, Okusaka T, Tanaka N, Kuriyama H, Yoshimori M. Ikeda M, et al. Among authors: okusaka t. Hepatogastroenterology. 2000 May-Jun;47(33):862-5. Hepatogastroenterology. 2000. PMID: 10919048 Clinical Trial.

6

Prognostic factors in patients with metastatic pancreatic adenocarcinoma receiving systemic chemotherapy.

Ueno H, Okada S, Okusaka T, Ikeda M. Ueno H, et al. Among authors: okusaka t. Oncology. 2000 Nov;59(4):296-301. doi: 10.1159/000012186. Oncology. 2000. PMID: 11096341

7

Predictive factors for tumor response to chemotherapy in patients with pancreatic cancer.

Fujishiro M, Okada S, Ueno H, Okusaka T, Ikeda M, Watanabe H, Tanaka N. Fujishiro M, et al. Among authors: okusaka t. Hepatogastroenterology. 2000 Nov-Dec;47(36):1744-6. Hepatogastroenterology. 2000. PMID: 11149046

8

Prognostic factors in patients with locally advanced pancreatic carcinoma receiving chemoradiotherapy.

Ikeda M, Okada S, Tokuuye K, Ueno H, Okusaka T. Ikeda M, et al. Among authors: okusaka t. Cancer. 2001 Feb 1;91(3):490-5. doi: 10.1002/1097-0142(20010201)91:3<490::aid-cncr1027>3.0.co;2-l. Cancer. 2001. PMID: 11169931

9

Phase I trial of gemcitabine in patients with advanced pancreatic cancer.

Okada S, Ueno H, Okusaka T, Ikeda M, Furuse J, Maru Y. Okada S, et al. Among authors: okusaka t. Jpn J Clin Oncol. 2001 Jan;31(1):7-12. doi: 10.1093/jjco/hye003. Jpn J Clin Oncol. 2001. PMID: 11256843 Clinical Trial.

10

Radiofrequency ablation and percutaneous ethanol injection in patients with small hepatocellular carcinoma: a comparative study.

Ikeda M, Okada S, Ueno H, Okusaka T, Kuriyama H. Ikeda M, et al. Among authors: okusaka t. Jpn J Clin Oncol. 2001 Jul;31(7):322-6. doi: 10.1093/jjco/hye063. Jpn J Clin Oncol. 2001. PMID: 11518745

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

545 results

Search Page

Filters